345 related articles for article (PubMed ID: 25651904)
1. Risk of breast cancer among users of estrogen plus progestogen and unopposed estrogen: is the likelihood of bias symmetrical?
Shapiro S
Climacteric; 2015 Jun; 18(3):333-5. PubMed ID: 25651904
[No Abstract] [Full Text] [Related]
2. Does hormone replacement therapy cause breast cancer? An application of causal principles to three studies: part 3. The Women's Health Initiative: unopposed estrogen.
Shapiro S; Farmer RD; Mueck AO; Seaman H; Stevenson JC
J Fam Plann Reprod Health Care; 2011 Oct; 37(4):225-30. PubMed ID: 21642263
[TBL] [Abstract][Full Text] [Related]
3. Breast cancer risk during hormone therapy: experimental versus clinical data.
Ruan X; Seeger H; Mueck AO
Minerva Endocrinol; 2012 Mar; 37(1):59-74. PubMed ID: 22382615
[TBL] [Abstract][Full Text] [Related]
4. Postmenopausal hormone therapy and breast cancer.
Prescrire Int; 2009 Apr; 18(100):66-7. PubMed ID: 19585723
[TBL] [Abstract][Full Text] [Related]
5. Epidemiologic aspects of exogenous progestagens in relation to their role in pathogenesis of human breast cancer.
van Leeuwen FE
Acta Endocrinol (Copenh); 1991; 125 Suppl 1():13-26. PubMed ID: 1801500
[TBL] [Abstract][Full Text] [Related]
6. Reliable evidence from placebo-controlled, randomized, clinical trials for menopausal hormone therapy's influence on incidence and deaths from breast cancer.
Chlebowski RT; Anderson GL; Prentice RL; Rossouw JE; Aragaki AK; Manson JE
Climacteric; 2015 Jun; 18(3):336-8. PubMed ID: 25966858
[TBL] [Abstract][Full Text] [Related]
7. Postmenopausal hormone replacement therapy: does the progestin make a difference?
Fylstra DL
J S C Med Assoc; 2002 Feb; 98(1):12-9. PubMed ID: 11859600
[No Abstract] [Full Text] [Related]
8. Hormone replacement therapy: estrogen after menopause.
Gibaldi M
Pharmacotherapy; 1996; 16(3):366-75. PubMed ID: 8726594
[No Abstract] [Full Text] [Related]
9. Endometrial carcinoma risks among menopausal estrogen plus progestin and unopposed estrogen users in a cohort of postmenopausal women.
Lacey JV; Brinton LA; Lubin JH; Sherman ME; Schatzkin A; Schairer C
Cancer Epidemiol Biomarkers Prev; 2005 Jul; 14(7):1724-31. PubMed ID: 16030108
[TBL] [Abstract][Full Text] [Related]
10. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women.
Colditz GA; Hankinson SE; Hunter DJ; Willett WC; Manson JE; Stampfer MJ; Hennekens C; Rosner B; Speizer FE
N Engl J Med; 1995 Jun; 332(24):1589-93. PubMed ID: 7753136
[TBL] [Abstract][Full Text] [Related]
11. Cancer issues.
Marsden J; Sturdee D
Best Pract Res Clin Obstet Gynaecol; 2009 Feb; 23(1):87-107. PubMed ID: 19036643
[TBL] [Abstract][Full Text] [Related]
12. Landmark hormone replacement therapy study stopped after finding more harms than benefits.
Rollins G
Rep Med Guidel Outcomes Res; 2002 Aug; 13(15):5-7. PubMed ID: 12553323
[No Abstract] [Full Text] [Related]
13. Prognostic characteristics of breast cancer among postmenopausal hormone users in a screened population.
Kerlikowske K; Miglioretti DL; Ballard-Barbash R; Weaver DL; Buist DS; Barlow WE; Cutter G; Geller BM; Yankaskas B; Taplin SH; Carney PA
J Clin Oncol; 2003 Dec; 21(23):4314-21. PubMed ID: 14645420
[TBL] [Abstract][Full Text] [Related]
14. Breast cancer risk with postmenopausal hormonal treatment.
Collins JA; Blake JM; Crosignani PG
Hum Reprod Update; 2005; 11(6):545-60. PubMed ID: 16150813
[TBL] [Abstract][Full Text] [Related]
15. Current status of hormone therapy and breast cancer.
Norman RJ; MacLennan AH
Hum Reprod Update; 2005; 11(6):541-3. PubMed ID: 16150811
[TBL] [Abstract][Full Text] [Related]
16. Progestogens in postmenopausal hormone therapy and the risk of breast cancer.
Lambrinoudaki I
Maturitas; 2014 Apr; 77(4):311-7. PubMed ID: 24485796
[TBL] [Abstract][Full Text] [Related]
17. Menopausal hormone therapy and cancer: changing clinical observations of target site specificity.
Chlebowski RT; Anderson GL
Steroids; 2014 Nov; 90():53-9. PubMed ID: 24910928
[TBL] [Abstract][Full Text] [Related]
18. Hormone replacement therapy and risk of breast cancer: the role of progestins.
Stahlberg C; Pedersen AT; Lynge E; Ottesen B
Acta Obstet Gynecol Scand; 2003 Apr; 82(4):335-44. PubMed ID: 12716318
[TBL] [Abstract][Full Text] [Related]
19. Risks and benefits of hormone therapy: has medical dogma now been overturned?
Shapiro S; de Villiers TJ; Pines A; Sturdee DW; Baber RJ; Panay N; Stevenson JC; Mueck AO; Burger HG
Climacteric; 2014 Jun; 17(3):215-22. PubMed ID: 24654673
[TBL] [Abstract][Full Text] [Related]
20. Postmenopausal hormone therapy and the risk of breast cancer: a contrary thought.
Speroff L
Menopause; 2008; 15(2):393-400. PubMed ID: 17925662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]